[1] Stewart JJ, Green CL, Jones N, Liang M, Xu Y, Wilkins DE, Moulard M, Czechowska K, Lanham D, McCloskey TW, Ferbas J. Role of receptor occupancy assays by flow cytometry in drug development. Cytometry Part B: Clinical Cytometry. 2016 Mar;90(2):110-6.
[2] Liang M, Schwickart M, Schneider AK, Vainshtein I, Del Nagro C, Standifer N, Roskos LK. Receptor occupancy assessment by flow cytometry as a pharmacodynamic biomarker in biopharmaceutical development. Cytometry Part B: Clinical Cytometry. 2016 Mar;90(2):117-27.